Discover how OSMA is advancing orthopaedic surgical solutions and fostering collaboration within the industry.
President
Driving innovation in medical devices for over 20 years, Ryan Belaney, President & CEO of Phoenix Kinetics, leverages his deep expertise in the full product life cycle to bring innovative technologies to market and improve patient outcomes. Ryan's journey began as a biomedical engineer at Osteotech Inc. and Wright Medical Technology, where he honed his skills in device development and regulatory. He then built upon his expertise to lead research, regulatory, quality, and clinical efforts at RTI Surgical, AgNovos Biosciences, and Active Implants, ultimately culminating in his current role at Phoenix Kinetics.
Beyond his leadership role, Ryan invests his time and expertise in the MedTech community, mentoring entrepreneurs in the Zero-to-510 accelerator and offering guidance to Orthoworld, Inc. as an Advisory Board member. This unwavering dedication to both innovation and community leadership reflects Ryan's commitment to shaping a brighter future for healthcare.
A graduate of the University of Mount Union, Ryan holds a BS in Biology with additional expertise in Chemistry and Psychology, alongside a master's degree in biomedical engineering from the University of Toledo.
Vice President
Valerie Giambanco is a Regulatory Affairs Manager on the Corporate Regulatory Affairs team at Stryker. Within this team, Valerie is dedicated to regulatory affairs process ownership and leading regulatory process updates and implementations across Stryker’s divisions. Prior to joining Stryker’s corporate team, Valerie dedicated 13 years in regulatory affairs to Stryker Orthopaedics, focusing on change control and new product development for joint replacement and trauma devices. As an elected board member of OSMA, Valerie is passionate about regulatory advocacy and educating future regulatory leaders in the orthopaedic industry.
Valerie holds a BS in Biomedical Engineering from University of Southern California (USC), MS in Regulatory Science from USC and MS in Management (Technology Management) from Stevens Institute of Technology.
Secretary
Lisa Boyle is the Director of Regulatory Affairs at Tyber Medical with 38 years of experience in the medical device industry. She began her career in Quality in 1985 before transitioning to Regulatory Affairs in 2001. Her role entails managing RA, ensuring compliance with post-market obligations, supporting MDD and MDR registrations across various regions, and navigating product classifications through the 510(k), IDE, and PMA processes.
Lisa has also been an active member of OSMA throughout her career, serving as both Secretary (2016-2018) and Vice President (2019) on its board. Currently, Lisa co-chairs the OSMA Planning Committee and serves as Secretary on the board. She earned her bachelor's degree from Cedar Crest College.
Treasurer
Hannah Foley, MS, MBA, Director of Regulatory Affairs - Knees and Shoulder at Johnson & Johnson (DePuy Synthes), leverages her comprehensive regulatory expertise to navigate complex global markets and bring innovative orthopedic devices to patients worldwide. Hannah's journey began at a small spine company, where she honed her skills in quality assurance and regulatory management, successfully achieving ISO 13485 certification. She then built upon this foundation at Symmetry Surgical and Johnson & Johnson (Cerenovus), progressing through roles of increasing responsibility across neurovascular and orthopedic portfolios, ultimately leading to her current roledirecting regulatory strategy for knee and shoulder devices across multiple global markets.
Beyond her leadership role, Hannah contributes her expertise to the orthopedic industry as Treasurer on the OSMA Board of Directors, where her strategic planning acumen and collaborative approach help advance the organization's mission. She is an active member of the Regulatory Affairs Professional Society, reflecting her commitment to fostering regulatory excellence and innovation across the medical device community.
A graduate of the University of New Hampshire with a BA in Modern American History, Hannah holds both a Master of Science in Marketing and a Global Master of Business Administration from Southern New Hampshire University, alongside certifications as a BSI ISO 9001 Lead Auditor and ISO 13485 Internal Auditor.
Board Member
Michael is currently serving as the Director of Regulatory Affairs at Innovasis, Inc. which manufactures over two dozen product systems for the lumbar, thoracic, cervical, and cranial regions. He has been the author or co-author of numerous 510(k)s and other market authorization submissions, bringing new products to market through collaboration with regulators. Michael’s experience is primarily focused on the US market but has also supported CE certification and withdrawal processes in response to the EU MDR and helped transition his company's QMS for multiple significant changes including but not limited to ISO 13485:2016 and the MDSAP audit model. He has also supported post-market surveillance processes for multiple product lines in the US, Australia, Brazil, and Canada. Innovasis also proudly supports a humanitarian program in Peru, which treats spinal pathologies in underprivileged communities.
Michael has a B.S. in Sociology from the University of Utah, holds the RAPS RAC credential for Medical Devices, and holds multiple certifications for medical device manufacturing.
Board Member
Karen Ariemma is the Regulatory Strategy Director at Stryker Orthopaedics with responsibility to provide strategic input and technical guidance on global regulatory requirements to support new product development and sustaining regulatory. She has over thirty-five years experience in the orthopaedic industry. She started her career as a research engineer at Stryker. Karen has diverse experience in various roles within pre and post market regulatory. She has supported global submission over a wide breadth of product and technologies including robotics; total joint, trauma, and spinal devices; 3D printed devices and patient specific implants and instrumentation.
Karen has a BS in Materials Engineer from Rensselaer Polytechnic Institute.
Board Member
Brianna is the Director of Regulatory Affairs at restor3d, a small-sized company focused on delivering innovative, patient-centric solutions by leveraging additive manufacturing. Brianna has played a pivotal role in the growth and success of restor3d, including its acquisitions of Kinos Medical and Conformis. Over the past 4 years with restor3d, she has helped the company secure multiple 510(k) clearances, an HDE approval and various breakthrough device designations. restor3d also has extensive experience in navigating the custom device exemption and compassionate use pathways to provide unique solutions to patients when alternative options do not exist. Additionally, Brianna leads post-market surveillance and sustaining regulatory efforts for the US, U.K. and EU markets.
Brianna has a B.S. in Biomedical Engineering from Georgia Institute of Technology. Her career began in R&D and Quality Engineering, providing essential experience in the total product lifecycle.
Board Member
David brings over 16 years of experience in global regulatory affairs, including more than 12 years in the orthopedic medical device industry. As head of the Regulatory Affairs department at Arthrex, a global medical device company and leader in new product development and medical education in orthopedics, David leads a global team, strategically guiding the organization toward rapid and compliant market access across the U.S., EU, and emerging markets. By championing lean methodologies and driving process optimizations, he has reduced time to market without compromising on quality or compliance.
As an elected board member of OSMA, David is dedicated to advancing regulatory pathways and fostering innovation within the medical device sector. He advocates for clear, consistent, and efficient regulatory practices, champions cross-functional collaboration, and drives forward-thinking solutions to expand patient access to medical technologies worldwide.
Board Member
Jennifer is the Regulatory Affairs Associate Director at Zimmer Biomet, where she oversees regulatory operations for multiple divisions including Upper Extremities, Sports Medicine, Restorative Therapies, CD Diagnostics, and Surgical. Jennifer has been instrumental in guiding Zimmer Biomet through critical regulatory transitions, including EU MDR preparation, Brexit-related Notified Body and Authorized Representative changes, and the implementation of UDI and DPM labeling updates. Over her 20-year career in medical device regulations, she has managed FDA submissions, developed international registration dossiers, and provided strategic regulatory direction for new product development. Jennifer leads a team of regulatory professionals, providing mentorship and ensuring departmental compliance with evolving domestic and international regulations.
